FDAnews

BIOTECH FINDING A CURE FOR ITS OWN DISEASE: LOSING MONEY

The U.S. biotechnology industry is finally getting closer to an elusive goal: breaking even. Despite its reputation for developing lifesaving drugs and providing high- paying jobs, the industry has lost tens of billions of dollars since Genentech, the first genetic engineering company, was founded 30 years ago this Friday.

International Herald Tribune (http://www.iht.com/articles/2006/04/04/business/biotech.php)